Aurobindo Pharma Limited — JV/Acquisition, 05-08-2026: Amalgamation/Merger

Aurobindo Pharma's wholly-owned Eugia Pharma is merging with its step-down subsidiaries Eugia Steriles and Eugia SEZ. This internal restructuring aims to simplify the group, cut costs, and boost synergy by combining their injectable pharma businesses. For FY26, Eugia Pharma posted a turnover of ₹2,725.90 Cr, Eugia Steriles ₹6.27 Cr, and Eugia SEZ ₹487.42 Cr. Shareholders face no dilution as Aurobindo Pharma's ownership remains unchanged. The Boards have approved this plan for NCLT filing.